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Summary
 
Brain aging is associated with a progressive imbalance
between antioxidant defenses and intracellular concentra-
tions of reactive oxygen species (ROS) as exemplified by
increases in products of lipid peroxidation, protein oxida-
tion, and DNA oxidation. Oxidative conditions cause not only
structural damage but also changes in the set points of redox-
sensitive signaling processes including the insulin receptor
signaling pathway. In the absence of insulin, the otherwise
low insulin receptor signaling is strongly enhanced by
oxidative conditions. Autophagic proteolysis and sirtuin
activity, in turn, are downregulated by the insulin signaling
pathway, and impaired autophagic activity has been
associated with neurodegeneration. In genetic studies,
impairment of insulin receptor signaling causes spectacular
lifespan extension in nematodes, fruit flies, and mice. The
predicted effects of age-related oxidative stress on sirtuins
and autophagic activity and the corresponding effects of
antioxidants remain to be tested experimentally. However,
several correlates of aging have been shown to be
ameliorated by antioxidants. Oxidative damage to mito-
chondrial DNA and the electron transport chain, pertur-
bations in brain iron and calcium homeostasis, and changes
in plasma cysteine homeostasis may altogether represent
causes and consequences of increased oxidative stress.
Aging and cognitive decline thus appear to involve changes
at multiple nodes within a complex regulatory network.
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Introduction
 
Aging research is currently dominated by two competing con-
cepts. The spectacular lifespan extension in certain mutants of
nematodes, fruit flies, or mice suggested the possibility that
aging may be a regulated process under the control of a few
‘aging genes’, notably genes involved in the insulin signaling
pathway and in the expression of certain ‘silent information –
regulating proteins’ or sirtuins (Kenyon 
 
et al
 
., 1993; Dorman
 
et al
 
., 1995; Kimura 
 
et al
 
., 1997; Hekimi & Guarente, 2003;
Howitz 
 
et al
 
., 2003; Sauve 
 
et al
 
., 2006). On the other hand,
there is a growing body of evidence supporting the ‘free-radical
theory of aging’ (Harman, 1956), which predicts that the
lifespan of an organism could be increased by augmenting anti-
oxidant defenses. In this review, we summarize recent findings
suggesting that the age-related increase in oxidative stress may
have a direct impact on the insulin signaling pathway and down-
regulate sirtuin proteins. This review focuses mainly on the cen-
tral nervous system although it is understood that many of the
principles outlined may be germane to aging in non-neural tissues.
The decline in cognitive and motor functions is one of the
hallmarks of ‘normal aging’ (Bartus, 1990; Kluger 
 
et al
 
., 1997).
It includes conspicuous changes in learning and memory, which
have been linked to the hippocampus, as well as a decline in
strength, balance, and coordination, which map to the basal
ganglia and cerebellum (Joseph, 1992; Bickford, 1993; McDonald
& White, 1994; Devan 
 
et al
 
., 1996; Oliveira 
 
et al
 
., 1997; Foster,
1999). In contrast to neurodegenerative diseases, the cognitive
decline in ‘normal aging’ may not be associated with a significant
loss of neurons (Gallagher 
 
et al
 
., 1996).
 
Evidence for an age-related increase in 
oxidative damage and decrease in antioxidant 
levels
 
The putative role of oxygen radicals and radical-derived reactive
oxygen species (ROS) in neurodegeneration and cognitive decline
has been reviewed previously (Gallagher 
 
et al
 
., 1996; Berr 
 
et al
 
.,
2000; Serrano & Klann, 2004). The age-related increase in
oxidative brain damage is best exemplified by products of lipid
peroxidation (Gupta 
 
et al
 
., 1991; Cini & Moretti, 1995; Murray
& Lynch, 1998; O’Donnel & Lynch, 1998; Calabrese 
 
et al
 
., 2004;
Richwine 
 
et al
 
., 2005; Zhu 
 
et al
 
., 2006), protein oxidation
(Forster 
 
et al
 
., 1996; Mohsen 
 
et al
 
., 2005; Sigueira 
 
et al
 
., 2005;
Poon 
 
et al
 
., 2006), and oxidative modifications in nuclear and
mitochondrial DNA (Hamilton 
 
et al
 
., 2001). An increase in
protein carbonyl levels has been demonstrated for various brain
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regions including the hippocampus (Mohsen 
 
et al
 
., 2005, Siqueira
 
et al
 
., 2005).
Age-related memory impairment is correlated with a decrease
in brain and plasma antioxidants (Perrig 
 
et al
 
., 1997; Perkins
 
et al
 
., 1999; Berr 
 
et al
 
., 2000; Rinaldi 
 
et al
 
., 2003). Intracellular
glutathione (GSH) concentration as well as the ratio of glutathione :
glutathione disulfide (GSH : GSSG ratio) were found to decrease
with age in different animal models (Chen 
 
et al
 
., 1989; Iantomasi
 
et al
 
., 1993; Oubidar 
 
et al
 
., 1996; Pallardo 
 
et al
 
., 1999; Sasaki
 
et al
 
., 2001; Liu, 2002; Sandhu & Kaur, 2002; Rebrin 
 
et al
 
., 2003;
Wang 
 
et al
 
., 2003; Suh 
 
et al
 
., 2004, 2005). This decrease in GSH
level and/or GSH : GSSG ratio was found in all mammalian brain
regions tested including the hippocampus (Calabrese 
 
et al
 
.,
2004; Balu 
 
et al
 
., 2005; Donahue 
 
et al
 
., 2006; Zhu 
 
et al
 
., 2006).
As cysteine is the most limiting precursor for intracellular GSH
biosynthesis, it is reasonable to hypothesize that the decrease
in intracellular GSH may be mechanistically related to the age-
related decrease in post-absorptive plasma cysteine that has
been found in humans between the third and the ninth decade
of life (Hack 
 
et al
 
., 1998). Most cells and tissues have relatively
strong membrane transport activity for reduced cysteine and
weak or no transport activity for its relatively large oxidized
derivative, cystine.
 
Age-related derangement of redox-regulated 
signals
 
As ROS production by various tightly regulated NAD(P)H oxidase,
isoenzymes is known to play a role in many redox-sensitive sig-
naling pathways, any increase in ROS levels and/or any oxidative
shift in the thiol-disulfide redox status may cause a shift in the
set points of numerous physiological processes (reviewed in
Dröge, 2002). The age-related increase in the steady state level
of interleukin 6 (IL-6) mRNA and IL-6 production in the brain
(Ye & Johnson, 1999; Richwine 
 
et al
 
., 2005) is only one case in
point. 
 
In vivo
 
 and 
 
in vitro
 
 studies indicate that this increase
results from enhanced binding of the redox-sensitive transcrip-
tion factor nuclear factor 
 
κ
 
 B (NF-
 
κ
 
B) to the IL-6 promoter in
microglial cells (Ye & Johnson, 1999, 2001). The age-related
increase in IL-6 is reminiscent of the systemic increase in the
concentration of the inflammatory cytokine, tumor necrosis
factor 
 
α
 
 (TNF-
 
α
 
), which is also controlled by NF-
 
κ
 
B. The increase
in TNF-
 
α
 
 was ameliorated by treatment with the GSH prodrug
N-acetyl cysteine (NAC) (reviewed in Dröge, 2005b).
 
Redox sensitivity of the insulin signaling 
pathway and the role of autophagy and sirtuin 
proteins
 
The insulin receptor is expressed throughout the brain, including
the hippocampus (Dou 
 
et al
 
., 2005; Wada 
 
et al
 
., 2005; Benedict
 
et al
 
., 2006). The importance of the insulin signaling pathway
in aging has been convincingly demonstrated by genetic studies
of nematodes, fruit flies, and mice. In all of these species, a dramatic
lifespan extension was often associated with an impairment of
the insulin receptor signaling pathway or with an increased
expression of sirtuin family proteins, which are negatively regulated
by this signaling cascade (Kenyon 
 
et al
 
., 1993; Dorman 
 
et al
 
., 1995;
Kimura 
 
et al
 
., 1997; Hekimi & Guarente, 2003, Howitz 
 
et al
 
.,
2003; Rogina & Helfand, 2004; Sauve 
 
et al
 
., 2006). A substan-
tial lifespan extension of 
 
Caenorhabditis elegans
 
, for example,
was achieved by a mutation in 
 
daf-2
 
, which encodes an insulin
receptor ortholog. Lifespan was negatively affected by the target
of rapamycin (TOR), which functions downstream in the insulin
receptor signaling pathway (Kapahi 
 
et al.
 
, 2004). By activating
TOR or its mammalian counterpart mTOR, the insulin receptor
signaling pathway downregulates the expression of proteins
of the sirtuin family and the autophagic mechanism of proteolysis
(schematically illustrated in Fig. 1; reviewed in Dröge, 2005a).
The autophagic mechanism of proteolysis plays an important
role in the maintenance of cellular integrity by removing (dam-
aged) mitochondria and other organelles (reviewed in Dröge,
2003). Not unexpectedly, autophagy was shown to be required
for lifespan extension in longevity mutants of 
 
C. elegans
 
 (Melendez
 
et al
 
., 2003). Mice genetically engineered to lack either of the
autophagy genes 
 
Atg5
 
 or 
 
Atg7
 
 in neuronal cells during later
stages of embryogenesis develop signs of neurodegeneration
and eventually show inclusion bodies akin to those seen in
various human aging-related neurodegenerative disorders (Hara
 
et al
 
., 2006; Komatsu 
 
et al
 
., 2006). In line with this finding,
there is ample evidence implicating proteolytic stress in a wide
range of neurodegenerative diseases (Ciechanover & Brundin,
2003; Bossy-Wetzel 
 
et al
 
., 2004). Emerging evidence supports
the view that induction of autophagy is a neuroprotective
response and that inadequate or defective authophagy, rather
Fig. 1 Oxidative upregulation of the insulin receptor signaling cascade in the 
absence of insulin. Akt, serine/threonine kinase PKB; IRS-1, insulin-receptor 
substrate; INS-RK, insulin receptor tyrosine kinase; PDK1, phosphoinositide-
dependent protein kinase-1; PI3K, phosphatidylinositol-3 kinase; PTEN, 
phosphatase and tensin homolog on chromosome 10; PTP1B, protein tyrosine 
phosphatase 1B; PI(3,4)P2, phosphatidylinositol(3,4) diphosphate; PI(4,5)P2, 
phosphatidylinositol(4,5) diphosphate; PI(3,4,5)P3, phosphatidylinositol 
(3,4,5) triphosphate; SHIP2, SH2-domain-containing inositol phosphatase; 
TOR/mTOR, (mammalian) target of rapamycin. The question mark indicates 
that H2O as a product of this reaction has not been formally proven (for other 
details see text). 
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than excessive autophagy, promotes neuronal cell death in most
neurodegenerative disorders (Nixon, 2006; Rubinsztein, 2006).
Signs of excessive autophagy have been reported in patients
with Alzheimer’s disease (AD) but are uncommon in brains devoid
of AD pathology (Nixon 
 
et al
 
., 2005).
Sirtuin proteins are a family of protein deacetylases, which
regulate a diverse set of pathways implicated in the aging process
(reviewed in Hekimi & Guarente, 2003). Certain sirtuins were
found to regulate glucose and fat metabolism in mammals
(Guarente & Picard, 2005; Rodgers 
 
et al
 
., 2005) and to enhance
mitochondrial biogenesis in liver and muscle through the tran-
scriptional coactivator peroxisome proliferator-activator receptor-
 
γ
 
coactivator 1
 
α
 
 (PGC-1
 
α
 
) (Rodgers 
 
et al
 
., 2005; Lerin 
 
et al
 
., 2006),
and cell survival by deactivating the tumor surpressor, p53
(Smith, 2002). In view of these multiple effects, the exact role
of sirtuin proteins in the aging process remains obscure. The
plant-derived polyphenol, resveratrol, was found to increase the
catalytic (deacetylase) activity of certain sirtuin proteins and to
extend the lifespan of yeast by 70% (Howitz 
 
et al
 
., 2003). In
the short-lived fish, 
 
Nothobranchius furzeri
 
, resveratrol
extended the maximum lifespan by 60%, delayed the decay of
locomotor activity and cognitive performance, and attenuated
neurofibrillary degeneration in the brain (Valenzano 
 
et al
 
.,
2006). Middle-aged mice on a high-calorie diet that were
treated with resveratrol for the remainder of their life showed
a significantly increased lifespan, increased postprandial insulin
sensitivity, AMP-activated protein kinase (AMPK), and PGC-1
 
α
 
activity, increased mitochondrial numbers, and improved motor
function (Baur 
 
et al
 
., 2006). Whether sirtuin proteins similarly
influence human aging is not known.
As autophagy and sirtuin expression are down-regulated by
the insulin signaling cascade, it is inferred that autophagy and
sirtuin activity are optimally expressed when circulating insulin
levels are low, that is, in the post-absorptive state during the
night (see Fig. 2). This important point remains to be confirmed.
The insulin-independent 
 
basic
 
 activity of the insulin receptor
signaling pathway (i.e. its activity in the post-absorptive state
during the night) is weak but subject to redox regulation (see
Fig. 1). The signaling cascade is negatively controlled by several
phosphatases, including protein tyrosine phosphatase 1B (PTB
1B), phosphatase and tensin homolog on chromosome 10 (PTEN)
and SH2-domain-containing inositol phosphatase (SHIP2), all of
which are inactivated under moderately oxidative conditions. In
addition, the 
 
basic
 
 insulin receptor tyrosine kinase (Ins-RK) activity
is strongly increased by low concentrations of hydrogen peroxide
or by an oxidative shift in the GSH redox status (Schmitt 
 
et al
 
.,
2005). In the presence of adenosine 5’-triphosphate (ATP) and
hydrogen peroxide, the insulin receptor kinase domain is phos-
phorylated at its catalytic site and thereby rendered catalytically
active in the absence of insulin (schematically illustrated in Fig. 3).
The phosphatases, in turn, contain a redox-sensitive cysteine
moiety in their catalytic site, which is converted by hydrogen
peroxide into a sulfenic acid moiety, which renders the phos-
phatase inactive (Fig. 3). The balance between kinase and phos-
phatase activities determines the rate of phosphorylation of the
insulin receptor kinase domain and several downstream targets
including the phosphatidylinositol phosphates, the serine/
threonine kinase Akt1 and the TOR. Ultimately, this balance
controls the aging-related functions of autophagy and sirtuin
proteins (Fig. 1). The redox sensitivity of the 
 
basic
 
 insulin receptor
signaling activity 
 
in vivo
 
 has been confirmed in a clinical study
of nondiabetic obese persons in whom basic (i.e. post-absorptive)
insulin receptor signaling was decreased after supplementation
with relatively small doses of NAC (Hildebrandt 
 
et al
 
., 2004). It
is therefore conceivable that autophagic proteolysis and sirtuin
activity may be compromised by the oxidative conditions that
prevail in old age as schematically illustrated in Fig.  2. This
important prediction remains to be confirmed.
 
Effects of GSH enhancing antioxidants on 
oxidative damage and functional decline – 
suggestive evidence for a cause–effect 
relationship
 
N-acetyl cysteine is widely used both in clinical medicine and in
experimental animal studies to increase the availability of
Fig. 2 Interrelated changes of insulin receptor signaling, autophagy, and 
sirtuin expression during the day (hypothetical scheme). The solid lines 
illustrate the temporal changes in young healthy subjects. During the night, 
that is, in the post-absorptive state, insulin receptor signaling is low and 
autophagy and sirtuin activity are accordingly high. In the aging organism 
(dashed lines), the age-related oxidative shift in redox status leads to an 
increased basic signaling activity from the insulin receptor in spite of low 
insulin levels; autophagy and sirtuin expression are accordingly suppressed. 
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cysteine and intracellular GSH, that is, the quantitatively most
important cellular antioxidant. Feeding of NAC-containing
pellets (0.3% w/w) to 48-week-old mice for 24 weeks caused
a significant decrease in protein carbonyls in synaptic mitochon-
dria of the brain in comparison with untreated controls (Bana-
clocha 
 
et al
 
., 1997). Chronic dietary administration of NAC was
also shown to preserve mitochondrial proteins involved in oxi-
dative phosphorylation in the liver of senescent mice (Miquel
 
et al
 
., 1995). Feeding of NAC-containing pellets (0.3% w/w) to
mice from 12 months until killed at 28 months resulted in a
significant increase in ADP-stimulated respiration in brain mito-
chondria. In addition, NAC treatment reversed the age-related
decline in cytochrome 
 
c
 
 content and the decrease in cytosolic
GSH in the brain (Cocco 
 
et al
 
., 2005).
The age-related decline in memory function was also
ameliorated by NAC in a recent study on rats. Again, this was
associated with diminished levels of protein oxidation and lipid
peroxides in brain synaptic mitochondria (Martinez 
 
et al
 
., 2000).
Furthermore, a diet containing 7.2 mg NAC per day significantly
attenuated the accelerated, age-related cognitive dysfunction
observed in transgenic mice overexpressing growth hormone
(Lemon 
 
et al
 
., 2003). The excitatory amino acid carrier 1 (EAAC1)
serves as a transporter for glutamate, aspartate and reduced L-
cysteine. Although EAAC1 is not the only cysteine transporter,
EAAC1 deficient mice (EAAC1
 
–/–
 
) have relatively low neuronal
(hippocampal) GSH levels and, with advancing age, develop
brain atrophy and behavioral changes. Increasing cysteine
availability in these animals by intraperitoneal injections of
150 mg kg
 
–1
 
 of NAC normalized brain GSH concentrations and
decreased the extent of neuronal death after oxidant exposure
(Aoyama 
 
et al
 
., 2006). Collectively, these data attest to the
important contribution of the thiol redox status in the pre-
servation of healthy cognition in aging rodents.
(R)-
 
α
 
-Lipoic acid (LA) is a coenzyme involved in mitochondrial
redox processes. The reduced form of LA chelates iron and copper
and recycles several antioxidants including GSH and vitamins C
and E (Packer 
 
et al
 
., 1997; Moini 
 
et al
 
., 2002). Feeding of LA
(0.2% w/w for 2 weeks) to 24- to 28-month-old rats reversed
the age-related increase in iron levels and the age-related decrease
in GSH and ascorbic acid levels in the brain (Suh et al., 2005).
Several reports described positive effects of LA in combination with
acetyl-L-carnitine on memory and brain mitochondrial functions
in old rats (Liu et al., 2002a,b). Rats that were fed LA exhibited
improved spatial learning and memory (Stoll et al., 1994).
Other experimental strategies to ameliorate 
oxidative damage
The radical scavenger α-phenyl-tert-butyl-nitrone (PBN) has
potent salutary effects in certain aging-related diseases (reviewed
in Floyd et al., 2002). Intraperitoneal administration of PBN in
aged gerbils for 14 days caused a significant decrease in brain
levels of oxidized protein and improved performance in a tem-
poral and spatial memory test when compared to age-matched
controls. The same treatment had no effect on young adult
gerbils (Carney et al., 1991). Similar results have been obtained
in mice (Fredriksson & Archer, 1996). Chronic systemic adminis-
tration of synthetic catalytic scavengers of ROS (i.e. superoxide
dismutase/catalase mimetics) to mice for 3 months between 8
and 11 months of age almost completely reversed not only the
increase in brain oxidative damage but also the cognitive deficits
(Liu et al., 2003). It remains to be determined whether these
antioxidative treatments may have a GSH sparing effect and
indirectly elevate cellular GSH levels.
Supportive evidence for a role of oxidative stress in aging has
also been obtained in animal studies of calorie restriction. A
restriction of dietary calories results in significant lifespan exten-
sion in diverse organisms (Sohal & Weindruch, 1996; Weindruch
& Walford, 1997). In several independent studies of mice, rats,
and fruit flies, the increased survival of calorically restricted ani-
mals was associated with a decrease in tissue oxidative damage
(Hamilton et al., 2001; Sohal et al., 1994; Zheng et al., 2005).
Also, in a series of long-lived strains of worms, flies, and mice,
the increased lifespan was correlated with increased oxidative
stress resistance (Orr & Sohal, 1994; Lin et al., 1998; Parkes et al.,
1998; Honda & Honda, 1999; Lee et al., 1999; Migliaccio et al.,
1999; Taub et al., 1999). Again, GSH levels have not been reported.
Putative mechanisms accounting for the 
age-related increase in oxidative damage: 
changes in antioxidant enzymes
Several authors suggested the possibility that the increase in
oxidative stress may result, at least partly, from a relative decrease
Fig. 3 Oxidative activation of insulin receptor kinase and inactivation of 
phosphatases (schematic illustration). Upper panel: in the absence of insulin, 
basic insulin receptor kinase (Ins-RK) activity is relatively low. Hydrogen 
peroxide oxidizes cysteine sulfhydryl (SH) groups into sulfenic acid moieties 
(S-OH). This oxidative process allows adenosine 5’-triphosphate (ATP) to 
phosphorylate the insulin receptor kinase at its catalytic site and to render 
the kinase catalytically active. Lower panel: phosphatases typically contain an 
SH group at their catalytic center. Upon oxidation by hydrogen peroxide the 
phosphatase is converted into a catalytically inactive intermediate and other 
inactive derivatives. The question marks indicate that these reaction products 
have not been formally proven.Oxidative stress in aging and cognitive decline, W. Dröge and H. M. Schipper
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in antioxidant enzyme activities (Tian et al., 1998; Navarro et al.,
2004; Sigueira et al., 2005). A decline in GSH peroxidase activity
has been found in hippocampus and hypothalamus of aged rats
(Sigueira et al., 2005). A decrease in the activities of Mn and
CuZn superoxide dismutase isoenzymes and catalase has been
found in the brain, heart, liver, and kidney of aging mice (Gupta
et al., 1991; Navarro et al., 2004). A decrease in the apparent
catalytic turnover of γ-glutamyl cysteine ligase (GCL) and/or
GCL subunit expression has been found in old rats (Liu, 2002).
However, it should be noted that an age-related decline in
brain antioxidant enzyme activities has not been confirmed
by other investigators and remains controversial (Serrano &
Klann, 2004).
Oxidative mitochondrial damage as part 
of a vicious cycle leading to increased ROS 
production
Mitochondria are widely believed to play a key role in aging
because they are a major source of oxygen radicals and arguably
their most important targets. Mitochondrial DNA is particularly
vulnerable to oxidative damage and shows a more than ten-fold
greater mutation rate than nuclear DNA. Mutated mitochondrial
DNA may code for abnormal cytochromes and may cause in-
fidelity of the electron transport chain associated with increased
superoxide radical production and a vicious cycle of progres-
sively increasing oxidative stress (Linnane et al., 1992; Finkel &
Holbrook, 2000; Sohal et al., 2002; Hekimi & Guarente, 2003;
Sastre et al., 2003; Vina et al., 2003; Navarro & Boveris, 2004;
Schipper, 2004; Balaban et al., 2005). Moreover, accumulation
of peroxidation products in mitochondria leads to a decrease
in ATP production and compromises the maintenance of cellular
homeostasis (Chance et al., 1979). Mitochondrial dysfunction
and mitochondria-derived ROS have been implicated in both
normal brain aging and neurodegenerative diseases (Toescu &
Verkhratsky, 2003; Lin & Beal, 2006). A study of rat brain mito-
chondria also revealed an age-related increase in mitochondrial
fragility, volume, and water permeability (Navarro & Boveris,
2004). In the mammalian central nervous system (CNS), cellular
senescence is often associated with the accumulation of
mitochondria-derived cytoplasmic inclusions such as Gomori-
positive glial granules and corpora amylacea (Brunk & Terman,
2002; Schipper, 2004). Evidence supporting the free radical-
mitochondrial theory of aging has accrued from a broad range
of in vitro studies and whole animal models from unicellular
organisms to mammals. However, the theory is not immune from
controversy and some investigators maintain that aging exerts
no adverse effect on either the electron transport chain or
oxidative phosphorylation (Maklashina & Ackrell, 2004).
Dysregulation of iron homeostasis as 
a potential cause of oxidative stress
Free iron is a potential source of oxidative stress because it
catalyses the conversion of hydrogen peroxide into highly reac-
tive hydroxyl radicals by the Fenton reaction. In addition, iron-
dependent lipid peroxidation may also generate potentially toxic
peroxyl/alkoxyl radicals (Gutteridge, 1982), and ferrous free iron
may convert neutral catechols (e.g. dopamine) to neurotoxic
o-semiquinone intermediates (Schipper, 2004). An age-related
increase in iron content has been found in human brain tissue
(Martin et al., 1998) as well as rat and mouse brain (Cook &
Yu, 1998; Sohal et al., 1999; Donahue et al., 2006). In rats the
concentrations of several metals, including iron, increase in
the hippocampus and frontal cortex (Donahue et al., 2006). In the
aging human brain, excessive iron accumulation associated with
markers of free radical injury and mitochondrial DNA deletion
are most prominent in the basal ganglia, hippocampus, and
certain cerebellar nuclei (Soong et al., 1992). In rat astrocytes
hydrogen peroxide was found to induce the heme-degrading
enzyme heme oxygenase 1 (HO-1), which fosters the liberation
of free cytosolic Fe
++ (Mydlarski et al., 1993). HO-1 may there-
fore exacerbate brain aging processes by engaging in a neuro-
pathological vicious cycle of ROS generation (Schipper, 2004).
The most common cell type in the brain to stain for iron under
normal conditions is the oligodendrocyte (Connor & Menzies,
1999). In humans, an age-related increase in iron staining and
ferritin immunoreactivity was found in microglia and astrocytes
in various brain regions including the hippocampus (Zecca et al.,
2004). Thus, aging-related oxidative stress may participate in a
vicious cycle of events characterized by dysregulation of cellular
iron homeostasis, mitochondrial insufficiency, bioenergetic fail-
ure and augmented ROS generation by the electron transport
chain. Iron chelators, free radical scavengers and inhibitors of
glial HO-1 expression, alone or in combination, may be useful
in the management of aging-related human neurodegenerative
afflictions (Schipper, 2004). The observation that brain iron
levels can be reduced in old rats by oral administration of the
blood-brain barrier-permeable chelator, LA (Suh et al., 2005)
may be an important step in this direction.
Dysregulation of calcium homeostasis and 
oxidative stress
Another potential vicious cycle  may involve changes in the
cytosolic and mitochondrial calcium concentration (Toescu &
Verkhratsky, 2003; Foster, 2006). Well-controlled temporary
elevations of cytosolic calcium concentrations play a role in
numerous cellular signaling systems and are typically induced
by the release of calcium from the endoplasmic reticulum (ER)
(reviewed in Toescu & Verkhratsky, 2003). A growing body of
evidence suggests that the calcium channels, which control cal-
cium efflux from the ER in response to different biochemical
signals, are also sensitive to small changes in ROS concentrations
or changes in the intracellular thiol redox status, suggesting that
these calcium channels serve as physiological redox sensors
(Okabe et al., 2000; Pessah & Feng, 2000; reviewed in Camello-
Almaraz et al., 2006; Zima & Blatter, 2006). Effects of hydrogen
peroxide on calcium fluxes have been demonstrated in rat
hippocampal cells, cortical astrocytes, and dentate granule cellsOxidative stress in aging and cognitive decline, W. Dröge and H. M. Schipper
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(Jacobson & Duchen, 2002; Akaishi et al., 2004; Gonzalez et al.,
2006). Robust elevation of cytosolic calcium causes calcium flux
into the mitochondrial matrix, which, in turn, enhances mito-
chondrial ROS production, thereby completing the vicious cycle
(Van de Water et al., 1994; Bindokas et al., 1996). Increased
mitochondrial calcium concentrations combined with increased
ROS production are characteristic of neurodegenerative conditions,
such as AD and ischemic brain injury (Toescu & Verkhratsky,
2003; Starkov et al., 2004). It has been suggested that calcium-
dependent mitochondrial ROS production may also play a role
in normal cellular physiology (see Hongpaison et al., 2003).
There is a strong possibility that the age-related oxidative shift
in redox status may cause subpathological changes in calcium
homeostasis and especially changes in the kinetics of calcium
fluctuations (see Toescu & Verkhratsky, 2003). Whether these,
in turn, may have a substantial effect on mitochondrial ROS pro-
duction remains to be ascertained.
Age-related decrease in plasma cysteine 
concentration
Neurons exhibit relatively strong membrane transport activity
for the small amino acid, cysteine but weak transport activity
for its larger oxidized derivative cystine. Therefore, and because
the plasma concentration of reduced cysteine is extremely low
in comparison to most other amino acids, cysteine is the limiting
amino acid for GSH biosynthesis in neural and most other cells
(Bannai & Tateishi, 1986; Aoyama et al., 2006). Clinical studies
have shown that the post-absorptive plasma cysteine concen-
tration in healthy human subjects decreases significantly between
the third and ninth decade of life (Hack et al., 1998; Dröge, 2005b).
Supplementation with NAC or a cysteine-rich protein has been
shown to improve muscular strength and other functional and
biochemical parameters, which are typically compromised in old
age (Hauer et al., 2003; reviewed in Dröge, 2005a,b).
Why the 70-year-old seemingly healthy subject has, on
average, a substantially lower post-absorptive plasma con-
centration of reduced cysteine than a 20-year-old person with
the same dietary protein intake remains enigmatic. The basic
biochemical mechanisms of cysteine biosynthesis, utilization, and
catabolism are well known, and yet the mechanisms responsible
for the age-related changes in cysteine homeostasis remain
obscure. These changes may be related to the facts that (i) in
the postprandial state, a substantial proportion of the dietary
cysteine is normally converted into hepatic GSH and proteins,
which serve as a reservoir for cysteine (Cho et al., 1984; Cheema-
Dhadli & Halperin, 1993), and (ii) the rate of postprandial
protein synthesis per time unit decreases with age (Volpi et al.,
2000; Dardevet et al., 2002; Combaret et al., 2005; Fujita &
Volpi, 2006). As the hepatic concentration of free cysteine is a
key regulator of its own catabolism into sulfate (Stipanuk et al.,
1992; Lee et al., 2004), we tentatively assume that the post-
absorptive cysteine concentration in old age decreases as a
consequence of the age-related decrease in postprandial
protein synthetic capacity and the resulting failure to rapidly
clear dietary cysteine before it is catabolized into sulfate. To
understand and to reverse these changes in cysteine homeostasis
may be a worthwhile and achievable goal in the near future.
Conclusions
There is an impressive body of evidence (i) for an age-related
increase in oxidative stress in both humans and experimental
animals, (ii) for the redox sensitivity of the insulin signaling cas-
cade as demonstrated by numerous molecular studies, and (iii)
for the dramatic impact of the insulin receptor signaling cascade
and insulin-controlled sirtuin proteins on the lifespan of nema-
todes, fruit flies, and mice as demonstrated by genetic studies.
There is therefore a strong possibility that oxidative enhance-
ment of the insulin receptor signaling pathway may have an
even greater impact on aging than the direct oxidative damage
to structural constituents. In spite of the persuasive mosaic of
data, there are still many information gaps especially regarding
the extrapolation of animal data to humans. With regard to
insulin-controlled, aging-related functions, there is suggestive
evidence that inadequate autophagic proteolysis does play a
role including in human aging, but we still do not know whether
sirtuins or resveratrol are capable of influencing fundamental
aging processes in humans. Also, the predicted effects of the
age-related oxidative stress on autophagy and sirtuin activity as
well as the corresponding putative effects of antioxidants have
not yet been demonstrated experimentally.
The notion that oxidative stress plays a causative role in age-
related functional decline is not proven but it is already strongly
supported by the effects of antioxidants on various correlates
of aging. This review has been somewhat biased in favor of thiol
containing and GSH enhancing antioxidants and may not have
done justice to other types of antioxidants and ROS scavengers.
One of the reasons for this bias is the large number of reports
concerning the effects of NAC and the thiol compound α-LA.
In patients with AD, NAC was shown to improve certain cog-
nitive tasks (Adair et al., 2001). In our view, understanding and
reversing age-related changes in plasma thiol (cysteine) home-
ostasis is an achievable goal with important implications for the
amelioration of a broad spectrum of neurological and systemic
conditions linked to the aging process.
The abundant evidence for an age-related increase in prod-
ucts of oxidative damage in the mammalian brain is in good
agreement with findings in other tissues (reviewed in Beckman
& Ames, 1998; Dröge, 2002). ROS-mediated mitochondrial
damage, the increase in iron deposition, dysregulation of Ca
++
homeostasis and post-absorptive plasma cysteine homeostasis,
and impaired autophagy and sirtuin activity secondary to aber-
rant insulin receptor signaling may represent several pivotal
mechanisms in a vicious cycle leading to progressively increasing
intracellular ROS concentrations and oxidative stress.
Taken together, the evidence suggests that aging is not
mediated by a single gene or by a single ‘master mechanism’
of oxidative damage but may rather result from progressive
dysregulation in a complex functional network as illustratedOxidative stress in aging and cognitive decline, W. Dröge and H. M. Schipper
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schematically in Fig. 4. In thermodynamic terms this reflects an
increase in entropy. Similar conclusions were recently expressed
by Drachman (2006) with respect to the multiplicity of cellular
and molecular mechanisms that contribute to senescence in the
human brain. Certain genes or certain biochemical processes
may, nevertheless, contribute more than others. If this concept
is basically correct, a cocktail of multiple interventions that
simultaneously targets several of the most important nodes in
this network may be required to limit age-related dyshomeostasis.
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